Most importantly, upregulation of the long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment resistance toward tyrosine kinase inhibitors (TKIs) in squamous cell carcinoma. Here, EGFR is linked to squamous cell carcinoma.